Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04920201
Other study ID # 2021-03-052
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 7, 2021
Est. completion date September 30, 2021

Study information

Verified date February 2023
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This single-blinded, randomized, controlled trial includes 60 healthy adults. The participants were randomized to four different groups. The first group performed over-ground walking without GEMS-H, the second group performed over-ground walking with GEMS-H applied resistance mode, the third group performed stair ascent with GEMS-H applied assist mode, and the fourth group were designated as the group that performed inclined gait with GEMS-H applied assist mode on a treadmill. Each group is divided in 15 participants.


Description:

At the first visit, the subjects are fully informed of the study if appropriate after determining whether they meet the selection criteria. If the subjects meet the selection criteria, the participants were randomized to four different groups. The first group performed over-ground walking without GEMS-H, the second group performed over-ground walking with GEMS-H with resistance mode, the third group performed stair ascent with GEMS-H with assist mode, and the fourth group were designated as the group that performed inclined gait with GEMS-H with assist mode on a treadmill. Each group is divided in 15 participants. Each group completed 30 minutes exercise at least three times per week (total 10 sessions). All measurements were conducted before and after the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date September 30, 2021
Est. primary completion date September 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years to 84 Years
Eligibility Inclusion Criteria: - Healthy adults aged 50 to less than 85 years without a history of central nervous system disease Exclusion Criteria: - Those who have difficulty walking independently due to problems such as visual field defects or fractures - Those with severe arthritis or orthopedic problems limiting passive range of motion (ROM) of the lower extremities (knee flexion contracture >10°, knee flexion ROM <90°, hip flexion contracture >25°, ankle plantar flexion contracture >15°) - Those who have difficulty understanding the exercise program due to severe cognitive decline (Korean-Mini-Mental State Examination, K-MMSE=10) - Those who have difficulty participating in exercise programs due to adult diseases such as uncontrolled hypertension and diabetes - Those who are at risk of falling while walking due to severe dizziness - Those who are less than 140 cm or more than 185 cm in height that is not suitable size for the wearing of the walking assistance robot - Those who are overweight based on body mass index (BMI) 35 or higher

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Over-ground walking without GEMS-H
Over-ground walking without GEMS-H (30 min per session, at least 3 times per weeks, total 10 sessions)
Device:
Over-ground walking with GEMS-H with resist mode
Over-ground walking with GEMS-H with resist mode (30 min per session, at least 3 times per weeks, total 10 sessions)
Stair ascent with GEMS-H with assist mode
Stair ascent with GEMS-H with assist mode (30 min per session, at least 3 times per weeks, total 10 sessions)
Incline walking with GEMS-H with assist mode
Incline walking with GEMS-H with assist mode (30 min per session, at least 3 times per weeks, total 10 sessions)

Locations

Country Name City State
Korea, Republic of Samsung Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline performance on gait speed after the intervention Measure of self selected speeds by measuring the time it takes an individual to walk 10 meters. To perform the test, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: "Please walk this distance at your normal pace when I say go." Baseline, After the intervention(day12)
Secondary Change from baseline performance on muscle strength after the intervention All subjects underwent measurements of muscle strength of lower extremity by using Commander Echo Muscle Tester (measures in lb, kg, N) Baseline, After the intervention(day12)
Secondary Change from baseline performance on Short Physical Performance Battery (SPPB) after the intervention The Short Physical Performance Battery (SPPB) is a series of tests used to evaluate lower extremity function and mobility. Baseline, After the intervention(day12)
Secondary Change from baseline performance on Functional Reach Test (FRT) after the intervention Functional Reach Test (FRT) is a clinical outcome measure and assessment tool for ascertaining dynamic balance in one simple task. Baseline, After the intervention(day12)
Secondary Change from baseline performance on Four Square Step Test (FSST) after the intervention Four Square Step Test (FSST) is a test of dynamic balance and coordination that clinically assesses the participant's ability to step over objects forward, sideways, and backwards. Baseline, After the intervention(day12)
Secondary Change from baseline performance on Berg Balance Scale (BBS) after the intervention Berg Balance Scale (BBS) is a 14-item objective measure that assesses static balance and fall risk in adults. Baseline, After the intervention(day12)
Secondary Change from baseline performance on Timed Up and Go test (TUG) after the intervention The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down. Baseline, After the intervention(day12)
Secondary Change from baseline performance on Geriatric Depression Scale (GDS) after the intervention The Geriatric Depression Scale (GDS) is a self-report measure of depression. Baseline, After the intervention(day12)
Secondary Change from baseline performance on EuroQol 5 Dimensions (EQ-5D) after the intervention EQ-5D is an instrument which evaluates the generic quality of life developed in Europe and widely used. The EQ-5D descriptive system is a preference-based HRQL measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Baseline, After the intervention(day12)
Secondary Change from baseline performance on Fall Efficacy Scale-Korea (FES-K) after the intervention The Falls Efficacy Scale (FES) is a ten-item test rated on a 10-point scale from not confident at all to completely confident. Baseline, After the intervention(day12)
Secondary Change from baseline performance on metabolic energy expenditure after the intervention All subjects underwent measurements respiratory metabolism energy during treadmill walking at a comfortable speed for 5 minutes. It assess the change of metabolic energy expenditure using a portable cardiopulmonary metabolic system (K5, Rome, Italy). Baseline, After the intervention(day12)
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A